AstraZeneca has turned to another digital health partner to support its aspirations in chronic kidney disease (CKD), joining forces with Aptar to develop algorithms that can be used to detect CKD ...

Metastatic renal cell carcinoma can affect the body in different ways depending on the location it has spread to. Learn more here.